Factors influencing the collection of peripheral blood stem cells in patients with acute myeloblastic leukemia and non-myeloid malignancies

Leukemia Research

Volumn 27, Issue 1, 2003, Pages 5-12

  Carral, A ^a   De la Rubia, J ^a   Martin G ^a   Molla S ^a   Martinez J ^a   Sanz, G F ^a   Soler, M A ^a   Jarque, I ^a   Jimenez C ^a   Sanz, M A ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Acute myeloid leukemia; Collection; Mobilization; Non myeloid malignancies; Stem cells

Indexed keywords

CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; BLOOD CELL COUNT; BLOOD SAMPLING; CANCER CHEMOTHERAPY; CELL MOTILITY; COLONY FORMING UNIT GM; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; MYELOID LEUKEMIA; PERIPHERAL BLOOD STEM CELL; PREDICTION; PRIORITY JOURNAL;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; BLOOD CELL COUNT; BONE MARROW; COLONY-FORMING UNITS ASSAY; DRUG SYNERGISM; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; LEUKAPHERESIS; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; NEOPLASMS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RADIOTHERAPY; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SAFETY; TREATMENT OUTCOME;

EID: 0037212633     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(02)00068-1     Document Type: Article

References (49)

1. Gratwohl A., Passweg J., Baldomero H., Hermans J. Blood and marrow transplantation activity in Europe 1997: European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant. 24:1999;231.
2. Alegre A., Tomas J.F., Martínez-Chamorro C., Gil-Fernandez J.J., Fernández-Villalta M.J., Arranz R.et al. Comparison of peripheral blood progenitor cell mobilization in patients with multiple myeloma: high-dose cyclophosphamide plus GM-CSF versus G-CSF alone. Bone Marrow Transplant. 20:1997;211.
3. Desikan K.R., Barlogie B., Jagannath S., Vesole D.H., Siegel D., Fassas A.et al. Comparable engraftment kinetics following peripheral blood stem cell infusion mobilized with granulocyte colony-stimulating factor with or without cyclophosphamide in multiple myeloma. J. Clin. Oncol. 16:1998;1547.
4. Bensinger W., Appelbaum F., Rowley S., Storb R., Sanders J., Lilleby K.et al. Factors that influence collection and engraftment of autologous peripheral blood stem cells. J. Clin. Oncol. 13:1995;2547.
5. Watts M.J., Sullivan A.M., Jamieson E., Pearce R., Fielding A., Devereux S.et al. Progenitor cell mobilization after low-dose cyclophosphamide and granulocyte colony-stimulating factor: an analysis of progenitor cell quantity and quality and factors predictive for these parameters in 101 pre-treated patients with malignant lymphoma. J. Clin. Oncol. 15:1997;535.
6. Schwartzberg LS, 1993. Peripheral blood stem cell mobilization in the outpatient setting. In: Wunder EW, Hénon PR, editors. Peripheral Blood Stem Cell Autograft. Heidelberg: Springer, 1993. 177 p.
7. Moskowitz C.H., Glassman J.R., Wuest D., Maslak P., Reich L., Gucciardo A.et al. Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma. Clin. Cancer Res. 4:1998;311.
8. Haas R., Möhle R., Frühauf S., Goldschmidt H., Witt B., Flentje M.et al. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood. 83:1994;3787.
9. Weaver C.H., Schwartzberg L.S., Birch R., Greco F.A., Rhinehart S., Hainsworth J.et al. Collection of peripheral blood progenitor cells after the administration of cyclophosphamide, etoposide and granulocyte colony-stimulating factor: an analysis of 497 patients. Transfusion. 37:1997;896.
10. Dreger P., Klöss M., Petersen B., Haferlach T., Löffler H., Loeffler M.et al. Autologous progenitor cell transplantation: prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts. Blood. 86:1995;3970.
11. Sautois B., Fraipont V., Baudoux E., Fassotte M.F., Hermanne J.P., Jérusalem G.et al. Peripheral blood progenitor cell collections in cancer patients: analysis of factors affecting the yields. Haematologica. 84:1999;342.
12. Schlenk R.F., Dohner H., Pforsich M., Benner A., Fischer K., Hartmann F.et al. Successful collection of peripheral blood progenitor cells in patients with acute myeloid leukaemia following early consolidation therapy with granulocyte colony-stimulating factor-supported high-dose cytarabine and mitoxantrone. Br. J. Haematol. 99:1997;386.
13. Jowitt S.N., Chang J., Morgenstern G.R., Howe T., Ryder W.D., Testa N.G.et al. Factors which affect the CFU-GM content of the peripheral blood haemopoietic progenitor cell harvests in patients with acute myeloid leukaemia. Br. J. Haematol. 100:1998;688.
14. Sanz M.A., de la Rubia J., Sanz G.F., Martín G., Martínez J., Jarque I.et al. Busulfan plus cyclophosphamide followed by autologous blood stem cell transplantation for patients with acute myeloblastic leukemia in first complete remission: a report from a single institution. J. Clin. Oncol. 11:1993;1661.
15. de la Rubia J., Sanz G.F., Martín G., Martínez J., Cervera J., Solves P.et al. Autologous blood stem cell transplantation for acute myeloblastic leukemia in first complete remission: intensification therapy before transplantation does not prolong disease-free survival. Haematologica. 84:1999;125.
16. Heil G., Hoelzer D., Sanz M.A., Lechner K., Liu Ying J.A., Papa G.et al. A randomized, double-blind, placebo-controlled, phase III study of filgrastim in remission induction and consolidation therapy for adults with de novo acute myeloid leukemia: The International Acute Myeloid Leukemia Study Group. Blood. 90:1997;4710.
17. de la Rubia J., Sanz M.A. Técnicas para la movilización y recolección de células hematopoyéticas. Sangre. 36:1991;181.
18. Iscove N.N., Senn J.S., Till J.E., McCulloch E.A. Colony formation by normal and leukemic human marrow cells in culture: effect of conditioned medium from human leukocytes. Blood. 37:1971;1.
19. + cell determination by flow cytometry: International Society of Hematotherapy and Graft Engineering. J. Hematother. 5:1996;213.
20. Pettengell R., Testa N.G., Swindell R., Crowther D., Dexter T.M. Transplantation potential of hematopoietic cells released into the circulation during routine chemotherapy for non-Hodgkin's lymphoma. Blood. 82:1993;2239.
21. Stewart D.A., Guo D., Morris D., Poon M.C., Ruether B.A., Jones A.R.et al. Superior autologous blood stem cell mobilization from dose-intensive cyclophosphamide, etoposide, cisplatin plus G-CSF than from less intensive chemotherapy regimens. Bone Marrow Transplant. 23:1999;111.
22. Marit G., Thiessard F., Faberes C., Cony-Makhoul P., Boiron J.M., Bernard P.et al. Factors affecting both peripheral blood progenitor cell mobilization and hematopoietic recovery following autologous blood progenitor cell transplantation in multiple myeloma patients: a monocentric study. Leukemia. 12:1998;1447.
23. 2) + G-CSF for PBSC mobilization in pre-treated lymphoma patients: a matched pair analysis. Blood. 88:1996;396a. [abstract 1571].
24. Desikan K.R., Barlogie B., Jagannath S., Vesole D.H., Siegel D., Fassas A.et al. Comparable engraftment kinetics following peripheral-blood stem cell infusion mobilized with granulocyte colony-stimulating factor with or without cyclophosphamide in multiple myeloma. J. Clin. Oncol. 16:1998;1547.
25. Zeller W., Guttensohn K., Stockschläder M., Dierlamm J., Kröger N., Koehne G.et al. Increase of mobilized CD34-positive peripheral blood progenitor cells in patients with Hodgkin's disease, non-Hodgkin's lymphoma and cancer of the testis. Bone Marrow Transplant. 17:1996;709.
26. Kröger N., Zeller W., Fehse N., Hassan H.T., Krüger W., Gutensohn K.et al. Mobilizing peripheral blood stem cells with high-dose G-CSF alone is as effective as with Dexa-BEAM plus G-CSF in lymphoma patients. Br. J. Haematol. 102:1998;1101.
27. Weaver C.H., Birch R., Greco F.A., Schwartzberg L., McAneny B., Moore M.et al. Mobilization and harvesting of peripheral blood stem cells: randomized evaluations of different doses of filgrastim. Br. J. Haematol. 100:1998;338.
28. Ketterer N., Salles G., Moullet I., Dumontet C., ElJaafari-Corbin A., Tremisi P.et al. Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies. Br. J. Haematol. 103:1998;235.
29. Tricot G., Jagannath S., Vesole D., Nelson J., Tindle S., Miller L.et al. Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients. Blood. 85:1995;588.
30. Gertz M.A., Lacy M.Q., Inwards D.J., Pineda A.A., Chen M.G., Gastineau D.A.et al. Factors influencing platelet recovery after blood cell transplantation in multiple myeloma. Bone Marrow Transplant. 20:1997;375.
31. Kotasek D., Shepherd K.M., Sage R.E., Dale B.M., Norman J.E., Charles P.et al. Factors affecting blood stem cell collections following high-dose cyclophosphamide mobilization in lymphoma, myeloma and solid tumors. Bone Marrow Transplant. 9:1992;11.
32. McQuaker I.G., Haynes A.P., Stainer C., Anderson S., Russell N.H. Stem cell mobilization in resistant or relapsed lymphoma: superior yield of progenitor cells following a salvage regimen comprising ifosphamide, etoposide and epirubicin compared to intermediate-dose cyclophosphamide. Br. J. Haematol. 98:1997;228.
33. Mauch P., Constine L., Greenberger J., Knospe W., Sullivan J., Liesveld J.L.et al. Hematopoietic stem cell compartment: acute and late effects of radiation therapy and chemotherapy. Int. J. Radiat. Oncol. Biol. Phys. 31:1995;1319.
34. Drake M., Ranaghan L., Morris T.C., Nolan L., Desai Z.R., Irvine A.E.et al. Analysis of the effect of prior therapy on progenitor cell yield: use of a chemotherapy scoring system. Br. J. Haematol. 98:1997;745.
35. Reiffers J. Peripheral blood stem cell transplantation in acute myeloid leukemia: the experience of the Bordeaux Group. Stem Cells. 13:1995;19.
36. Linker C.A., Ries C.A., Damon L.E., Sayre P., Navarro W., Rugo H.S.et al. Autologous stem cell transplantation for acute myeloid leukemia in first remission. Biol. Blood Marrow Transplant. 6:2000;50.
37. Chang J., Geary C.G., Testa N.G. Long-term bone marrow damage after chemotherapy for acute myeloid leukaemia does not improve with time. Br. J. Haematol. 75:1990;68.
38. Carlo-Stella C., Tabilio A., Regazzi E., Garau D., La Tagliata R., Trasarti S.et al. Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors. Bone Marrow Transplant. 20:1997;465.
39. Straetmans N., Herman P., Van Bockstaele D.R., Michaux L., Hagemeijer A., Ferrant A. Haemopoietic defect and decreased expansion potential of bone marrow autografts from patients with acute myeloid leukaemia in first remission. Br. J. Haematol. 101:1998;571.
40. Teshima T., Harada M., Takamatsu Y., Makino K., Taniguchi S., Inaba S.et al. Cytotoxic drug and cytotoxic drug/G-CSF mobilization of peripheral blood stem cells and their use for autografting. Bone Marrow Transplant. 10:1992;215.
41. Marit G, Boiron JM, Reiffers J. Acute myeloid leukaemia. In: Reiffers J, Goldman JM, Armitage JM, editors. Blood Stem Cell Transplantation. UK: Martin Dunitz Ltd., 1998. 91 p.
42. To L.B., Haylock D.N., Kimber R.J., Juttner C.A. High levels of circulating haemopoietic stem cells in very early remission from acute non-lymphoblastic leukaemia and their collection and cryopreservation. Br. J. Haematol. 58:1984;399.
43. Reid C.D., Kirk A., Muir J., Chanarin I. The recovery of circulating progenitor cells after chemotherapy in AML and ALL and its relation to the rate of bone marrow regeneration after aplasia. Br. J. Haematol. 72:1989;21.
44. Cantin G., Marchand-Laroche D., Bouchard M.M., Leblond P.F. Blood-derived stem cell collection in acute non-lymphoblastic leukemia: predictive factors for a good yield. Exp. Hematol. 17:1989;991.
45. Szer J., Juttner C.A., To L.B., Bradstock K.F., Sage R.E., Enno A.et al. Post-remission therapy for acute myeloid leukemia with blood-derived stem cell transplantation: results of a collaborative phase II trial. Int. J. Cell Clon. 10:1992;114.
46. Martín C., Torres A., León A., Rubio V., Alvarez M.A., Herrera C.et al. Autologous peripheral blood stem cell transplantation (PBSCT) mobilized with G-CSF in AML in first complete remission: role of intensification therapy in outcome. Bone Marrow Transplant. 21:1998;375.
47. Reichle A., Hennermann B., Meidenbauer N., Zaiss M., Bross K.J., Andreesen R. Peripheral blood stem cell transplantation (PBSCT) during consolidation treatment of the novo acute myelogenous leukemia. Blood. 88:1996;287b. [abstract 3874].
48. Armitage S., Hargreaves R., Samson D., Brennan M., Kanfer E., Navarrete C. CD34 counts to predict the adequate collection of peripheral blood progenitor cells. Bone Marrow Transplant. 20:1997;587.
49. + cell count in the peripheral blood for timing apheresis and maximizing yield. Transfusion. 39:1999;442.